
Vaccine UB-311 from Vaxxinity – Received FDA Fast Track Designation
Senior Home Care Roswell GA-On May 2, 2022, a biotechnology company by the name of Vaxxinity announced that it received fast track designation from the FDA for its development of a new class of immunotherapeutic vaccines for the treatment of Alzheimer’s.